Form EFFECT Cidara Therapeutics,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 9, 2026 |
| Accession Number: | 0001193125-26-005773 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Air Canada Welcomes New Collective Agreement with the IAMAW Ratified by its Technical Operations, Maintenance and Operational Support Employees
- Denise Hancock Announces A Murderous Mom, a True Story of Adoption, Violence, Survival, and the Search for Truth
- Waterbury Car Accident Attorney Dan Petroskey Explains Legal Options When an Unlicensed Driver Causes a Connecticut Crash
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share